drugset
Drugs / rAAV1.tMCK.human-alpha-sarcoglycan
last change Aug 2011 re-read 3 minutes ago

rAAV1.tMCK.human-alpha-sarcoglycan

Developed for
muscular dystrophy
Investigated by
Muscular Dystrophy Association · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Nationwide Children's Hospital

Trials 1

today NCT00494195 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00494195 Mar 2008 → Jun 2011 muscular dystrophy Nationwide Children's Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rAAV1.tMCK.human-alpha-sarcoglycan ClinicalTrials.gov intervention name — accepted as the source's own label NCT00494195 ↗
Route Intramuscular “intramuscular administration” NCT00494195 ↗